AHA Scientific Sessions 2026 Abstract · Nov 2, 2026
Right Ventricular-Pulmonary Artery Coupling as a Superior Predictor of Long-Term Mortality After Percutaneous Mitral Valve Interventions: A Retrospective Single-Center Experience
By Rivera F, Tsai CM, Lahr B et al.
Background: TAPSE/RVSP, the ratio of tricuspid annular plane systolic excursion to right ventricular systolic pressure, is an echocardiographic surrogate of RV-pulmonary arterial (RV-PA) coupling that integrates contractile reserve with afterload. Its comparative prognostic value versus TAPSE alone has not been established in large, contemporary percutaneous mitral valve cohorts. Hypothesis: Pre-procedural RV-PA uncoupling (TAPSE/RVSP ≤0.33 mm/mmHg) independently predicts long-term all-cause mortality and outperforms TAPSE alone in patients undergoing transcatheter mitral edge-to-edge repair (mTEER) or transcatheter mitral valve replacement (TMVR). Methods: This retrospective analysis included 525 consecutive patients undergoing mTEER or TMVR at Mayo Clinic (January 2015-December 2025). Uncoupled was defined as TAPSE/RVSP ≤0.33 mm/mmHg (n=259) versus coupled >0.33 (n=266). Kaplan-Meier survival estimates were compared by likelihood ratio testing. Cox proportional hazards models with restricted cubic splines evaluated TAPSE/RVSP and TAPSE as mortality predictors, unadjusted and adjusted for age, sex, Charlson comorbidity index, LVEF, and MR severity. Discrimination was assessed by C-index and adequacy index. Interaction analyses by sex and procedure type were performed. Results: Among 525 patients, 186 deaths occurred over median follow-up 2.8 years (IQR: 0.8-5.2). Uncoupled patients had significantly worse survival at 1 year (74.7% vs. 89.2%), 3 years (56.7% vs. 72.6%), and 5 years (38.8% vs. 58.3%; p=0.002), with early and sustained curve divergence. ( Figure 1 ) Abnormal TAPSE (≤1.7 cm) also predicted worse outcomes, though with less distinct separation (p=0.021). ( Figure 2 ) In unadjusted analysis, TAPSE/RVSP outperformed TAPSE alone (C-index: 0.619 vs. 0.585; adequacy: 0.99 vs. 0.45). After multivariable adjustment, TAPSE/RVSP remained an independent predictor (HR: 1.74, 95% CI: 1.12-2.68; p=0.002), whereas TAPSE lost significance (p=0.122). Partial effects plots demonstrated a monotonic inverse association between TAPSE/RVSP and log-relative hazard in unadjusted (p<0.001) and adjusted (p=0.002) models; TAPSE splines attenuated to non-significance after adjustment. TAPSE/RVSP provided incremental prognostic value beyond TAPSE (partial χ ² =10.0, p=0.018). ( Figure 3 ) Conclusion: Pre-procedural RV-PA uncoupling assessed by TAPSE/RVSP is a superior independent predictor of long-term mortality after percutaneous mitral valve interventions compared to TAPSE alone, with consistent effect across sex and procedure type. Routine pre-procedural reporting of TAPSE/RVSP may improve risk stratification for patients undergoing mTEER or TMVR.